Announce Date | 04/23/2024 |
EPS Normalized Actual | $0.06643 (Beat by $0.00643) |
EPS GAAP Actual | $0.06643 (Beat by $0.00643) |
Revenue Actual | $1.9568B |
Revenue Surprise | Beat by $1956.8M |
Announce Date | 07/01/2024 (Pre-Market) |
EPS Normalized Estimate | $2.26221 |
EPS GAAP Estimate | $2.26221 |
Revenue Estimate | $2.160597563B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | 9.6968 | 8.43 | 8.49 | 10.90361 | 2 |
Dec 2025 | 9.53 | 8.58 | 9.53 | 9.53 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | 1.16 | 1.16 | 1.9568B | 0.29% | 1956.8M |
FQ4 2021 (Dec 2021) | 1.42 | 1.42 | 2.1704B | 0.65% | 2170.4M |
FQ3 2021 (Sep 2021) | 1.88 | 1.88 | 1.9595B | 0.25% | 1959.5M |
FQ2 2021 (Jun 2021) | 2.58 | 2.58 | 2.1172B | 28.59% | 2117.2M |
FQ1 2021 (Mar 2021) | 2.16 | 2.16 | 1.9511B | 27.98% | 1951.1M |
FQ4 2020 (Dec 2020) | 3.2 | 3.2 | 2.1563B | 19.5% | 2156.3M |
FQ3 2020 (Sep 2020) | 2.7 | 2.7 | 1.9546B | 9.36% | 1954.6M |
FQ2 2020 (Jun 2020) | -3.82 | -3.82 | 1.5118B | -17.69% | 1511.8M |
FQ4 Announce Date
07/01/2024 (Pre-Market)
Consensus EPS Estimates
2.26221
Consensus Revenue Estimates
2.160597563B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 3.03843 | -- | 2.95152 | 3.11217 | 5 |
FQ3 2025 (Jul 2025) | 2.58597 | -- | 2.512 | 2.64873 | 5 |
FQ2 2025 (Jun 2025) | 2.408 | -- | 2.30233 | 2.49774 | 4 |
FQ1 2025 (Mar 2025) | 0.74 | -- | 0.70753 | 0.76758 | 6 |
FQ4 2024 (Oct 2024) | 2.74384 | -- | 2.6489 | 2.87676 | 10 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 2.3B | -- | 2.24B | 2.34B | 3 |
FQ3 2025 (Jul 2025) | 2.22B | -- | 2.17B | 2.26B | 3 |
FQ2 2025 (Jun 2025) | 2.18B | -- | 2.1B | 2.24B | 3 |
FQ1 2025 (Mar 2025) | 1.83B | -- | 1.77B | 1.88B | 5 |
FQ4 2024 (Oct 2024) | 2.23B | -- | 2.21B | 2.25B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | 1.16 | 1.16 | 100% | |
FQ4 2021 (Dec 2021) | 1.42 | 1.42 | 100% | |
FQ3 2021 (Sep 2021) | 1.88 | 1.88 | 100% | |
FQ2 2021 (Jun 2021) | 2.58 | 2.58 | 100% | |
FQ1 2021 (Mar 2021) | 2.16 | 2.16 | 100% | |
FQ4 2020 (Dec 2020) | 3.2 | 3.2 | 100% | |
FQ3 2020 (Sep 2020) | 2.7 | 2.7 | 100% | |
FQ2 2020 (Jun 2020) | -3.82 | -3.82 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $1.96B | $1956.8M | 100% |
FQ4 2021 (Dec 2021) | $0B | $2.17B | $2170.4M | 100% |
FQ3 2021 (Sep 2021) | $0B | $1.96B | $1959.5M | 100% |
FQ2 2021 (Jun 2021) | $0B | $2.12B | $2117.2M | 100% |
FQ1 2021 (Mar 2021) | $0B | $1.95B | $1951.1M | 100% |
FQ4 2020 (Dec 2020) | $0B | $2.16B | $2156.3M | 100% |
FQ3 2020 (Sep 2020) | $0B | $1.95B | $1954.6M | 100% |
FQ2 2020 (Jun 2020) | $0B | $1.51B | $1511.8M | 100% |